Literature DB >> 8965095

Evidence for central nervous system glial cell plasticity in phenylketonuria.

C A Dyer1, A Kendler, T Philibotte, P Gardiner, J Cruz, H L Levy.   

Abstract

Phenylketonuria (PKU) is caused by mutation(s) in the phenylalanine hydroxylase (PAH) gene which lead to deficient PAH activity and an accumulation of phenylalanine in the blood. The primary pathologic finding is hypomyelination and gliosis of central nervous system white matter. Similar white matter pathology is observed in the Pahenu2 mouse, a genetic model for PKU. We studied this mouse to examine the basis for these neuropathologic changes in PKU and to determine if hypomyelination and gliosis occur independently or are interrelated. Although white matter tracts within PKU brains are hypomyelinated, immunostaining and Western blot analyses revealed that these tracts contain abundant amounts of myelin markers, i.e. myelin basic protein (MBP), 2',3'-cyclic nucleotide 3'phosphohydrolase, and myelin/oligodendrocyte-specific protein (MOSP). However, Western blot analyses also showed that MBP isoform expression was aberrant. Investigation of individual cells was performed by extraction of tissue sections with Triton X-100. Most of the MOSP was extracted, with the remaining MOSP clearly visible in dual labeled cells, i.e. MOSP was colocalized along glial fibrillary acidic protein (GFAP) filaments. Cells expressing both MBP and GFAP were also identified in optic tract. Double labeling with a riboprobe for MBP and antibodies specific for GFAP revealed that the majority of GFAP-positive cells expressed MBP mRNA. Our in vitro studies examined the response of cultured wild type oligodendrocytes to elevated phenylalanine for 4 weeks (wk). Under these conditions, about 50 these conditions, about 50% of the oligodendrocytes expressed GFAP filaments and failed to elaborate membrane sheets. Proliferation of astrocytes appears not to be the source of gliosis, since the nuclei of GFAP-positive cells in the PKU brains did not immunostain for proliferating cell nuclear antigen. Dual-labeled cells were detected in normal mouse brain sections; however, PKU mouse white matter tracts were found to contain about twice the number of dual-labeled cells compared to normal tissue. Taken together, these data suggest that both myelinating and nonmyelinating oligodendrocytes are present in the normal adult brain, and that in response to a toxic factor such as elevated phenylalanine, myelinating oligodendrocytes adopt a nonmyelinating phenotype that expresses GFAP. Since myelinating Schwann cells and GFAP-positive nonmyelinating Schwann cells are normally present in adult peripheral nerve, and the myelinating Schwann cells react to pathologic situations by switching to GFAP-positive nonmyelinating cells, it may be that oligodendrocytes and Schwann cells are more similar than previously thought.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8965095     DOI: 10.1097/00005072-199607000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  23 in total

Review 1.  The structure and function of myelin: from inert membrane to perfusion pump.

Authors:  Charissa A Dyer
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

2.  Characterization of tremor in phenylketonuric patients.

Authors:  Belén Pérez-Dueñas; Josep Valls-Solé; Emilio Fernández-Alvarez; Jaon Conill; Maria Antonio Vilaseca; Rafael Artuch; Jaume Campistol
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

3.  MR imaging-based volumetry in patients with early-treated phenylketonuria.

Authors:  Nadine H Pfaendner; Gitta Reuner; Joachim Pietz; Gregor Jost; Dietz Rating; Vincent A Magnotta; Alexander Mohr; Bodo Kress; Klaus Sartor; Stefan Hähnel
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

4.  Pathologic and immunohistochemical findings in hypothalamic and mesencephalic regions in the pah(enu2) mouse model for phenylketonuria.

Authors:  Jennifer E Embury; Roger R Reep; Philip J Laipis
Journal:  Pediatr Res       Date:  2005-07-31       Impact factor: 3.756

5.  Oligodendrocyte development and myelinogenesis are not impaired by high concentrations of phenylalanine or its metabolites.

Authors:  Renaud Schoemans; Marie-Stéphane Aigrot; Chaohong Wu; Raphaël Marée; Pengyu Hong; Shibeshi Belachew; Claire Josse; Catherine Lubetzki; Vincent Bours
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

6.  A study of gene expression profiles of cultured embryonic rat neurons induced by phenylalanine.

Authors:  Huiwen Zhang; Xue Fan Gu
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

7.  An olfactory discrimination procedure for mice.

Authors:  S M Mihalick; J C Langlois; J D Krienke; W V Dube
Journal:  J Exp Anal Behav       Date:  2000-05       Impact factor: 2.468

8.  Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenylketonuric mice.

Authors:  Shelley R Winn; Tanja Scherer; Beat Thöny; Ming Ying; Aurora Martinez; Sydney Weber; Jacob Raber; Cary O Harding
Journal:  Mol Genet Metab       Date:  2017-10-19       Impact factor: 4.797

Review 9.  Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism.

Authors:  S Kölker; S W Sauer; G F Hoffmann; I Müller; M A Morath; J G Okun
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

10.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.